kodak & lt ; ek > buy stake in enzon & lt ; enzn > eastman kodak co said it ha acquir an 18.7 pct equiti interest in enzon inc , a pharmaceut compani special in protein therapi . kodak said it secur worldwid market right for three of enzon 's peg enzym use in the treatment of oxygen toxic disord , hyperuricemia and gout . the compani said it acquir two mln enzon share for 15 mln dlr , with loan to enzon of two mln dlr and interest of 30,000 dlr credit against the purchas price . kodak said the drug cover by the market right are in initi stage of the u.s. food and drug administr approv process . it said the invest should provid the necessari capit to complet the fda review process and provid a market outlet for the drug . the drug are peg-superoxid disdmutas and peg-catalas , for use against oxygen toxic disord that caus the often-fat tissu damag associ with sever burn , organ transplant , heart attack and trauma , and peg-uricas , for treatment of gout and other condit caus by the buildup of high level of uric acid in the bodi .